COLUMBIA, Mo. — A memory haunts Christina Fuhrman: the image of her toddler Pearl lying […]
Cómo COVID-19 resalta la incertidumbre de las pruebas médicas
La doctora Jacqueline Chu pensó en el hombre con una prueba de coronavirus negativa con […]
FDA Approves Verquvo
FDA Approves Verquvo (vericiguat) for Heart Failure with Reduced Ejection Fraction KENILWORTH, N.J.–(BUSINESS WIRE)– Merck […]
Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.
Thursday, December 10, 2020 FDA expected to make a decision on Emergency Use Authorization in […]
FDA Approves Imcivree
FDA Approves Imcivree (setmelanotide) for Chronic Weight Management in Patients with Obesity Due to POMC, […]
Moderna Has Completed Case Accrual for First Planned Interim Analysis of its mRNA Vaccine Against COVID-19 (mRNA-1273)
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nov. 11, 2020– Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) […]
CureVac Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate CVnCoV
TÜBINGEN, Germany / BOSTON, USA – October 23, 2020 — CureVac NV (Nasdaq: CVAC), a […]
Genentech Provides Topline Results From Investigator-Led Phase II/III Trial With Gantenerumab in Rare Inherited Form of Alzheimer’s Disease
South San Francisco, CA — February 9, 2020 — Genentech, a member of the Roche […]
Report: Drugmakers, distributors under federal opioid probe
At least a half-dozen companies that make or distribute prescription opioid painkillers are facing a […]
Optimizing the pharmaceutical industry
Research published in the International Journal of Simulation and Process Modelling shows how integrated simulations […]